GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Downtown: Genesis Lifestyle Medicine, Medi-Slim Weight Loss & Spa and Medical Reducing Inc. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
Tirzepatide seen from Downtown, without the jargon. Tirzepatide is often described as the 'next generation' of GLP-1s: a single drug that activates two hormone pathways instead of one.
Without insurance coverage, the brand-name price climbs fast; that is what pushes most patients to compare subscription programs that bundle the medication, monitoring, and delivery. Manufacturer savings cards and coupons exist for the brands, but eligibility depends on insurance status and indication.
Typical dosing: 2.5 - 5 - 7.5 - 10 - 12.5 - 15 mg/week, stepped up by tolerance and goal. Tirzepatide belongs to the 'Dual GIP + GLP-1 agonist (first twincretin molecule)' class and is given as a weekly subcutaneous injection. On the cost side, expect about $250-600/month compounded via telehealth; about $1,000-1,400/month brand-name without insurance. Local landmark: Genesis Lifestyle Medicine (7455 W Washington Ave # 140), rated 4.9/5 across 434 reviews.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.